Histopathology in the light of molecular profiling

Annals of Oncology

Volumn 17, Issue SUPPL. 4, 2006, Pages

  Stein, Harald ^a   Hummel, M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Burkitt lymphoma; Gene expression profiling; Large B cell lymphoma; Survival rates

Indexed keywords

CD20 ANTIGEN; EOSIN; HEMATOXYLIN; RITUXIMAB;

B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER CLASSIFICATION; CLINICAL FEATURE; CONFERENCE PAPER; CONSENSUS; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENOMICS; GERMANY; GIEMSA STAIN; HISTOPATHOLOGY; HUMAN; IMMUNOBLAST; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; REPRODUCIBILITY; SURVIVAL RATE; T LYMPHOCYTE; WORLD HEALTH ORGANIZATION;

GENE EXPRESSION PROFILING; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; PROGNOSIS;

EID: 33646868035     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdj990     Document Type: Conference Paper

References (4)

1. Rosenwald A, Wright G, Chan WC et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 1937-1947.
2. Shipp M, Ross KN, Tamayo P et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 2002; 8: 68-74.
3. Wright G, Tan B, Rosenwald A et al. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci USA 2003; 100: 9991-9996.
4. Delecluse HJ, Anagnostopoulos I, Dallenbach F et al. Plasmablastic lymphomas of the oral cavity: A new entity associated with the human immunodeficiency virus infection. Blood 1997; 89: 1413-1420.